Richard Gilson is Professor of Sexual Health and HIV Medicine at UCL and Honorary Consultant at the Mortimer Market Centre, Central and North West London NHS Foundation Trust. He is Director of the Centre for Clinical Research in Infection and Sexual Health, which is part of the UCL Institute for Global Health.
His research includes a programme of work on HPV infection, currently developing a screening strategy for the detection of anal pre-cancer in men who have sex with men living with HIV infection, funded by Cancer Research UK. He has a longstanding interest in hepatitis B and C virus infections, investigating both novel treatment approaches as well as prevention. Since the beginning of the COVID-19 pandemic, he has worked closely with colleagues at UCL and UCLH on treatment trials, and epidemiological studies both in healthcare settings and in the community.
He is a member of the Commission on Human Medicines at the MHRA and a member of expert working groups on COVID-19 therapeutics.